TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32282981

Group type: EXPERIMENTAL
Intervention: Dual-frequency bio-impedance analysis (DF-BIA)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Dual-energy X-ray absorptiometry (DXA)
Number of subjects: 31
Study: 33634740

Group type: EXPERIMENTAL
Intervention: Financial consequence frame
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Social consequence frame
Number of subjects: 348

Group type: COMPARATOR
Intervention: Health consequence frame
Number of subjects: 348
Study: 32057567

Group type: EXPERIMENTAL
Intervention: Diet HP (high protein/low carbohydrate)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Diet S (standard severe hypocaloric diet)
Number of subjects: 270
Study: 36092854

Group type: EXPERIMENTAL
Intervention: Structured Epidural Teaching Model (SETM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard Teaching Module (SDM)
Number of subjects: 44
Study: 616708360

Group type: EXPERIMENTAL
Intervention: Khanda Pippali Avaleha (10 g orally for 60 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Omeprazole (20 mg once a day for 60 days, empty stomach)
Number of subjects: 30
Study: 34465402

Group type: EXPERIMENTAL
Intervention: Direct maxillary sinus saline irrigation with systemic antibiotics and topical sprays (n = 24)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Pharmacological therapy alone (n = 15)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both groups (n = 39)
Number of subjects: 39
Study: 32090788

Group type: EXPERIMENTAL
Intervention: Rhodiola capsule (0.6 g/day) combined with sertraline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Rhodiola capsule (0.3 g/day) combined with sertraline
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sertraline with two placebos (0.6 g/day)
Number of subjects: 100
Study: 35299131

Group type: EXPERIMENTAL
Intervention: Carers with various potential stressors and resource availability
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Carers in employment, placements provided by a non-government organisation, and caring for >1 child in OOHC
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Carers satisfied with caseworker assistance
Number of subjects: 1143

Group type: EXPERIMENTAL
Intervention: Carers across four trajectory groups
Number of subjects: 1143
Study: 34358822

Group type: EXPERIMENTAL
Intervention: Very-low energy diet (VLED) of 1000 kcal/day for 8 weeks
Number of subjects: 64
Study: 34569878

Group type: EXPERIMENTAL
Intervention: MT alone (direct MT) with stent retrievers
Number of subjects: 404

Group type: COMPARATOR
Intervention: IVT + MT with stent retrievers
Number of subjects: 404
Study: 34373383

Group type: EXPERIMENTAL
Intervention: OSATS educational module for Pavlik harness application (group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (group 2)
Number of subjects: 40
Study: 32727393

Group type: EXPERIMENTAL
Intervention: Prospective feedback loop and tailored clinical response intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 21
Study: 35952766

Group type: EXPERIMENTAL
Intervention: Home-based strength training program
Number of subjects: 123

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 123
Study: 33711288

Group type: EXPERIMENTAL
Intervention: Screening at 12 months
Number of subjects: 5784

Group type: EXPERIMENTAL
Intervention: Initial screening
Number of subjects: 5784

Group type: EXPERIMENTAL
Intervention: Repeat screening
Number of subjects: 5784

Group type: EXPERIMENTAL
Intervention: Screening at 18 months
Number of subjects: 5784
Study: 33542153

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (active arm)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Placebo (control arm)
Number of subjects: 197
Study: 32383352

Group type: EXPERIMENTAL
Intervention: Aerobic training (4 weeks, stationary bicycle training, 5 times per week for 30 minutes)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Balance training (4 weeks, home training with easy, moderate, and/or hard exercises for the same duration)
Number of subjects: 20
Study: 32809966

Group type: COMPARATOR
Intervention: Normal saline vaginal wash (0.9% NaCl)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Alkaline vaginal wash (5% sodium bicarbonate)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Acidic vaginal wash (5% acetic acid)
Number of subjects: 218
Study: 35303841

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham-electroacupuncture
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 22
Study: 33653757

Group type: COMPARATOR
Intervention: Oral high-dose vitamin D supplementation (50,000 IU cholecalciferol) taken monthly for 2 years, with an initial loading dose of 500,000 IU cholecalciferol.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study: 32353142

Group type: EXPERIMENTAL
Intervention: Septum resection
Number of subjects: 257

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 257
Study: 35025149

Group type: EXPERIMENTAL
Intervention: Acupuncture (specific details on dosage and duration are not available)
Number of subjects: 0
Study: 34959924

Group type: EXPERIMENTAL
Intervention: Spinach extract supplementation (4 × 500 mg capsules/day; total 2 g per day) combined with moderate-intensity training (1 h session/3 times a week)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Spinach extract supplementation
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Spinach extract supplementation and physical training
Number of subjects: 45
Study: 33715956

Group type: EXPERIMENTAL
Intervention: Phosphorus-restricted diet (n = 36)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control diet (n = 35)
Number of subjects: 71
Study: 34608032

Group type: EXPERIMENTAL
Intervention: Vaginal electrical stimulation
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 48
Study: 35065045

Group type: EXPERIMENTAL
Intervention: FASTER-assisted ESD
Number of subjects: 6

Group type: COMPARATOR
Intervention: Conventional ESD
Number of subjects: 6
Study: 33818370

Group type: EXPERIMENTAL
Intervention: Managing Anxiety from Cancer (MAC), a seven-session CBT-based psychotherapy intervention delivered over the telephone
Number of subjects: 29

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 29
Study: 35793882

Group type: EXPERIMENTAL
Intervention: Moxibustion combined with plucking technique at Jiquan (HT 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care for PICC (Control)
Number of subjects: 80
Study: 32196623

Group type: EXPERIMENTAL
Intervention: 50 mg aspirin
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: 100 mg aspirin
Number of subjects: 446

Group type: COMPARATOR
Intervention: Control (normouricaemic subjects)
Number of subjects: 446

Group type: COMPARATOR
Intervention: Control (hyperuricaemic subjects)
Number of subjects: 446
Study: 35731056

Group type: EXPERIMENTAL
Intervention: Bone cement-enhanced APFN internal fixation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional PFNA internal fixation
Number of subjects: 42
Study: 33756239

Group type: EXPERIMENTAL
Intervention: Acute physical fatigue induced by a 30 s modified Wingate
Number of subjects: 20
Study: 36414575

Group type: EXPERIMENTAL
Intervention: Lipid-based nutritional supplement (LNS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 32727193

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage) for middle gastric cancer
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage) for middle gastric cancer
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage) for lower gastric cancer
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage) for lower gastric cancer
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage) for tumor in lesser curvature
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage) for tumor in lesser curvature
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycT stage) for tumor in non-lesser curvature
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycT stage) for tumor in non-lesser curvature
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage) for CT-ycN0
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage) for CT-ycN0
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage) for CT-ycN1
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage) for CT-ycN1
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage) for CT-ycN2
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage) for CT-ycN2
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Abdominal enhanced CT (CT-ycN stage) for CT-ycN3
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasound (EUS-ycN stage) for CT-ycN3
Number of subjects: 86
Study: 35283411

Group type: EXPERIMENTAL
Intervention: Dual group (aspirin plus cilostazol)
Number of subjects: 1188
Study: 32860470

Group type: EXPERIMENTAL
Intervention: Proposed randomised two-arm binary outcome trial design with stochastic curtailment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing designs with early stopping
Number of subjects: 0
Study: 32396535

Group type: EXPERIMENTAL
Intervention: Proficiency Based Progression (PBP) simulation training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PBP simulation training implemented across all workers
Number of subjects: 0
Study: 35221282

Group type: EXPERIMENTAL
Intervention: Ultra-low O2 (2%) tension
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control (5% O2 tension)
Number of subjects: 152
Study: 32229520

Group type: EXPERIMENTAL
Intervention: PARTNER 2 intervention
Number of subjects: 690

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 690
Study: 34275830

Group type: EXPERIMENTAL
Intervention: Propofol dosing based on total body weight (TBW)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Propofol dosing based on lean body weight (LBW)
Number of subjects: 22
Study: 32044943

Group type: EXPERIMENTAL
Intervention: Combination therapy (vancomycin or daptomycin + antistaphylococcal β-lactam)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Standard therapy (vancomycin or daptomycin alone)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 352

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Combination therapy (excluding dialysis patients)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Standard therapy (excluding dialysis patients)
Number of subjects: 352
Study: 35392818

Group type: EXPERIMENTAL
Intervention: Caregiver support training (manual based, 6 group sessions over 2 months)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 170
Study: 34602433

Group type: EXPERIMENTAL
Intervention: Propolis
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no propolis)
Number of subjects: 33
Study: 33196606

Group type: EXPERIMENTAL
Intervention: Acute exercise (60-min treadmill run at 65% ± 7% peak oxygen uptake)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acute exercise
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (resting for 9 h without exercise)
Number of subjects: 24
Study: 32505019

Group type: EXPERIMENTAL
Intervention: Stifneck® collar
Number of subjects: 60

Group type: COMPARATOR
Intervention: Philadelphia® collar
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both collars
Number of subjects: 60
Study: 33822852

Group type: EXPERIMENTAL
Intervention: Care staff proxies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Residents
Number of subjects: 0
Study: 32815921

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg daily for 12 weeks
Number of subjects: 30
Study: 34915723

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 33173072

Group type: EXPERIMENTAL
Intervention: CBCT machines (7 different types)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intra-operator reproducibility
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Inter-operator reproducibility
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Objective image quality measures and exposure parameters
Number of subjects: 7
Study: 35267911

Group type: EXPERIMENTAL
Intervention: Water-restricted (DEH) during walking/running at 55% V.O2max, 40 °C
Number of subjects: 10

Group type: COMPARATOR
Intervention: Maintained euhydration (EUH) during walking/running at 55% V.O2max, 40 °C
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Water-restricted (DEH)
Number of subjects: 10
Study: 35690783

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 61
Study: 34742285

Group type: EXPERIMENTAL
Intervention: Shamba Maisha intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study: 35695947

Group type: EXPERIMENTAL
Intervention: Group Comprehensive Behavioral Intervention for Tics (CBIT)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Group Educational Intervention for Tics (EIT)
Number of subjects: 55
Study: 36457090

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 33849030

Group type: EXPERIMENTAL
Intervention: Postnatal closure cohort
Number of subjects: 163

Group type: COMPARATOR
Intervention: Prenatal closure cohort
Number of subjects: 163
Study: 616120383

Group type: EXPERIMENTAL
Intervention: Anti-VEGF injections
Number of subjects: 40
Study: 33269580

Group type: EXPERIMENTAL
Intervention: Vagitories based on tea tree oil
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: St. John's wort-based vagitories
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Five herbs-based vagitories
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Vagitories based on St. John's wort
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Vagitories based on extracts of five plants
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: All investigated vagitories
Number of subjects: 210
Study: 33092618

Group type: EXPERIMENTAL
Intervention: Home non-invasive ventilation (NIV) strategies: 'rescue', 'non-targeted', and 'targeted'
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted home NIV with personalized ventilation settings and extensive monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-home NIV
Number of subjects: 0
Study: 33858718

Group type: EXPERIMENTAL
Intervention: MMRV (two doses)
Number of subjects: 3705

Group type: EXPERIMENTAL
Intervention: MMR + V (one dose of MMR followed by one dose of V)
Number of subjects: 3705

Group type: COMPARATOR
Intervention: MMR (control group, two doses)
Number of subjects: 3705

Group type: EXPERIMENTAL
Intervention: MMRV and MMR + V groups
Number of subjects: 3705

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 3705
Study: 36028843

Group type: EXPERIMENTAL
Intervention: Brief intervention using genetic polymorphism information (genotype testing using saliva, 30-min face-to-face or online intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional materials provided to the control group
Number of subjects: 0
Study: 33803814

Group type: EXPERIMENTAL
Intervention: HAplus gel (Aminogam gel®) applied to gingival tissue post-extraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HAplus gel enriched with vitamins C and E (TEST groups)
Number of subjects: 0

Group type: COMPARATOR
Intervention: HA-Control (HAplus-enriched medium without additional vitamins)
Number of subjects: 0
Study: 35388554

Group type: EXPERIMENTAL
Intervention: Participatory ergonomic (PE) intervention
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 263
Study: 33634332

Group type: EXPERIMENTAL
Intervention: All-inside technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Anteromedial portal technique (AMP)
Number of subjects: 80
Study: 32144829

Group type: EXPERIMENTAL
Intervention: Preoperative pelvic floor muscle training (PFMT) daily from inclusion to surgery (n=81)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group (no intervention; n=78)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Overall changes in all patients after surgery
Number of subjects: 159
Study: 34389577

Group type: EXPERIMENTAL
Intervention: Transitional Pain Service (TPS)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 176
Study: 35578230

Group type: EXPERIMENTAL
Intervention: Manual therapy (maximum of 6 sessions within 6 weeks, including spinal manipulation/mobilization, massage, and stretching)
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 409

Group type: COMPARATOR
Intervention: Advice to stay active (information from a physician on coping with pain, at 2 occasions within 3 weeks)
Number of subjects: 409

Group type: COMPARATOR
Intervention: Advice to stay active
Number of subjects: 409
Study: 33422394

Group type: EXPERIMENTAL
Intervention: Pacifier before feeding
Number of subjects: 72
Study: 36420808

Group type: EXPERIMENTAL
Intervention: Guided Mental Rehearsal (GMR)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Peer-learning (Control)
Number of subjects: 80
Study: 33629490

Group type: EXPERIMENTAL
Intervention: Haemoglobin levels of 70-89 g/l at 6+0 - 13+6 weeks
Number of subjects: 11976

Group type: EXPERIMENTAL
Intervention: Haemoglobin levels at 26-30 weeks of gestation
Number of subjects: 11976

Group type: EXPERIMENTAL
Intervention: Haemoglobin levels at 6+0 - 13+6 weeks and at 26-30 weeks of gestation
Number of subjects: 11976
Study: 33276610

Group type: EXPERIMENTAL
Intervention: Maternal self-referral
Number of subjects: 0

Group type: COMPARATOR
Intervention: Referral by community agency staff
Number of subjects: 0

Group type: COMPARATOR
Intervention: Referral by research staff
Number of subjects: 0
Study: 36482258

Group type: EXPERIMENTAL
Intervention: 300 mg NMN
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 600 mg NMN
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 900 mg NMN
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: NMN (all doses)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: HOMA-IR (all NMN doses)
Number of subjects: 80
Study: 33902326

Group type: EXPERIMENTAL
Intervention: Increased outdoor time
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Lack of outdoor time, school, and structured activities
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Increased snacking and more meals prepared and consumed at home
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Shift in sleep schedules
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Increase in leisure-based screen time
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Parental involvement in promoting activity and managing screen time
Number of subjects: 51
Study: 35679184

Group type: EXPERIMENTAL
Intervention: ENB‐EBUS‐GS group
Number of subjects: 385

Group type: COMPARATOR
Intervention: EBUS‐GS group
Number of subjects: 385
Study: 33772133

Group type: EXPERIMENTAL
Intervention: PRP + CaCl2 solution
Number of subjects: 16

Group type: COMPARATOR
Intervention: CaCl2 only
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 16
Study: 32891336

Group type: EXPERIMENTAL
Intervention: Functional jejunal interposition
Number of subjects: 113

Group type: COMPARATOR
Intervention: Roux-en-Y anastomosis
Number of subjects: 113
Study: 35711607

Group type: EXPERIMENTAL
Intervention: Auricular plaster therapy (APT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo/control APT
Number of subjects: 80
Study: 34222540

Group type: EXPERIMENTAL
Intervention: Benson's relaxation technique (listened to a voice containing relaxation technique twice a day for eight weeks)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 80
Study: 32395833

Group type: EXPERIMENTAL
Intervention: CT radiomics model based on a multicentric heterogeneous dataset with robust feature pre-selection (MCR)
Number of subjects: 124

Group type: COMPARATOR
Intervention: CT radiomics model based on a smaller standardized dataset without pre-selection (STD)
Number of subjects: 124
Study: 33515539

Group type: EXPERIMENTAL
Intervention: Ceritinib + AKT inhibitors (Capivasertib and Afuresertib)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AKT inhibitors (Capivasertib and Afuresertib) alone
Number of subjects: 0
Study: 33121605

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (AP) prescribing for invasive dental procedures in high-risk patients
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (AP) prescribing for invasive dental procedures in moderate-risk patients
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis (AP) prescribing for invasive dental procedures in low or unknown risk patients
Number of subjects: 160
Study: 36087590

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg orally every 12 h for 7 days followed by 4 mg orally every 12 h for 7 days
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo capsules for 14 days
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 149

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study: 32479903

Group type: EXPERIMENTAL
Intervention: Antimicrobial photodynamic therapy (aPDT) with chloro-aluminum phthalocyanine (AlClPc) and scaling and root planning (SRP)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Scaling and root planning (SRP) only
Number of subjects: 63